The platinum color mixed with the effortless style of the cowgirl bob achieved the perfect edgy look for me to feel like myself again. Now, weeks later, I still love it and can confirm it is a ...

One of them, the Italian bob haircut, has already been tried on by reality TV star Khloe Kardashian. Hairstylist Irinel de Leon presented the new look to her Instagram followers. She chose an ...

Let's discuss the wolf haircut, an audacious mash-up of a handful of most drastic styles that are trending today— the shag, the mullet, and the jellyfish hair cut. As its name suggests ...

Odeya Pinkus is a writer, who loves working on celebrity profiles, event coverage, and feature stories. Halsey is truly the queen of the pixie cute—there is no denying that. In fact, her short ...

Evangeline Lilly gained widespread recognition for her role as Kate Austen on Lost, the hit series that kept viewers hooked with its unpredictable twists and complex characters. As one of the show’s ...

Shares rise nearly 5% after upbeat forecast Drugmaker suggests demand for Zepbound and Mounjaro remains strong Lilly forecast earnings of $22.50 to $24.00 per share on an adjusted basis this year ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Eli Lilly (LLY) stock is higher Thursday after the pharmaceutical company beat profit expectations and matched revenue forecasts for its fourth quarter and issued a better-than-expected outlook ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to severely active Crohn's disease receiving ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of the JP Morgan ...